A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis
Condition: Bone Metastatic Non-small Cell Lung Cancer Interventions: Drug: AL2846; Drug: Zoledronic Acid Injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Reclast | Research | Study | Zometa